<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Neuropsychopharmacology</journal-id>
<journal-id journal-id-type="iso-abbrev">Neuropsychopharmacology</journal-id>
<journal-title-group>
<journal-title>Neuropsychopharmacology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0893-133X</issn>
<issn pub-type="epub">1740-634X</issn>
<publisher>
<publisher-name>Nature Publishing Group</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27402494</article-id>
<article-id pub-id-type="pmc">5143481</article-id>
<article-id pub-id-type="pii">npp2016121</article-id>
<article-id pub-id-type="doi">10.1038/npp.2016.121</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuropsychopharmacology Reviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse</article-title>
<alt-title alt-title-type="running">Glia as critical modulators of drug abuse</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lacagnina</surname>
<given-names>Michael J</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rivera</surname>
<given-names>Phillip D</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7620-6094</contrib-id>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bilbo</surname>
<given-names>Staci D</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="corresp" rid="caf1">*</xref>
</contrib>
<aff id="aff1"><label>1</label><institution>Department of Psychology &amp; Neuroscience, Duke University</institution>, Durham, NC, <country>USA</country></aff>
</contrib-group>
<author-notes>
<corresp id="caf1"><label>*</label><institution>Department of Pediatrics, Harvard Medical School, Massachusetts General Hospital East</institution>, CNY 114, Charlestown, MA 02129, <country>USA</country>, Tel: 617-643-9887, Fax: 617-724-1731, E-mail: <email>sbilbo@mgh.harvard.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>01</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epreprint">
<day>11</day>
<month>07</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>31</day>
<month>08</month>
<year>2016</year>
</pub-date>
<volume>42</volume>
<issue>1</issue>
<fpage>156</fpage>
<lpage>177</lpage>
<history>
<date date-type="received">
<day>01</day>
<month>03</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>24</day>
<month>06</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>06</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2017 American College of Neuropsychopharmacology</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>American College of Neuropsychopharmacology</copyright-holder>
</permissions>
<abstract>
<p>Drugs of abuse cause persistent alterations in synaptic plasticity that may underlie addiction behaviors. Evidence suggests glial cells have an essential and underappreciated role in the development and maintenance of drug abuse by influencing neuronal and synaptic functions in multifaceted ways. Microglia and astrocytes perform critical functions in synapse formation and refinement in the developing brain, and there is growing evidence that disruptions in glial function may be implicated in numerous neurological disorders throughout the lifespan. Linking evidence of function in health and under pathological conditions, this review will outline the glial and neuroimmune mechanisms that may contribute to drug-abuse liability, exploring evidence from opioids, alcohol, and psychostimulants. Drugs of abuse can activate microglia and astrocytes through signaling at innate immune receptors, which in turn influence neuronal function not only through secretion of soluble factors (eg, cytokines and chemokines) but also potentially through direct remodeling of the synapses. In sum, this review will argue that neural–glial interactions represent an important avenue for advancing our understanding of substance abuse disorders.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>